Neutralizing antibody (NAbs) positivity does not reduce the efficacy of interferon beta-1b (IFNbeta-1b) treatment, according to results of a substudy analysis of patients with a first event suggestive of multiple sclerosis (MS) in a multicentre, randomize
Therefore, these findings demonstrate not only that pregnancy has no adverse effects on the rate of MS relapses, but it also provides further evidence of the beneficial effects both of pregnancy and the postpartum period, over the long term, indicating a
The BENEFIT study (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment), sponsored by Bayer HealthCare, compared Betaseron treatment initiated after a first clinical event with delayed treatment.
Argentinean researchers conducted a small study to try to determine if parasitic worm infections conferred any benefits on MS sufferers.
Acquiring a regular tan during childhood may help to protect against the development of multiple sclerosis (MS) in later life, US research of twin pairs reveals.
The study, published in the latest edition of the journal Neurology, points out that multiple sclerosis (MS) is rarer but often more severe in African-Americans than in whites.
The cost of MS to the Canadian economy is estimated to be more than $1 billion per year.
Reporting in the May issue of the journal Archives of Neurology, Dr. Rhonda Voskuhl, the director of UCLA’s Multiple Sclerosis Program, and her colleagues have found that the application of a testosterone gel for men with MS reduced symptoms, slowed bra
The data suggest that FTY720 may have the potential to reduce neurodegeneration and enhance repair of the central nervous system (CNS) by modulating S1P receptors expressed on brain cells.
"We have shown for the first time that immediate treatment after a first clinical demyelinating event suggestive of MS can reduce the early neurological damage, which may ultimately delay the development of the debilitating sequelae that characterize adv
Rituxan cancer drug proved highly effective against multiple sclerosis in a small mid-stage trial, signaling a potentially more effective way of treating the progressive neurological disease.
An abundance of vitamin D seems to help prevent multiple sclerosis, according to a study in more than 7 million people that offers some of the strongest evidence yet of the power of the "sunshine vitamin" against MS.
But there is evidence that MS goes into remission when women become pregnant, and in some cases the body actually begins to repair some of the damage.
In patients with recently diagnosed multiple sclerosis, the extent of accumulated brain tissue loss and overall lesion load as determined by magnetic resonance imaging (MRI) may predict the rate of cerebral atrophy over the following two years, according
